Valuation: Sanofi

Market Cap 103B 113B 95.66B 86.52B 162B 10,592B 170B 1,156B 459B 5,724B 426B 417B 18,131B P/E 2026 *
13.8x
P/E 2027 * 11.5x
Enterprise Value 114B 125B 106B 95.61B 179B 11,705B 188B 1,278B 507B 6,325B 470B 460B 20,036B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.12x
Free-Float
88.8%
Yield 2026 *
4.94%
Yield 2027 * 5.21%
1 day-2.85%
1 week-4.76%
Current month+5.08%
1 month+18.00%
3 months+6.66%
6 months+11.42%
Current year+1.29%
1 week 81.93
Extreme 81.93
89
1 month 71.39
Extreme 71.39
89
Current year 69.75
Extreme 69.75
89
1 year 69.75
Extreme 69.75
89
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer - 01/09/2026
Director TitleAgeSince
Director/Board Member 61 30/04/2019
Director/Board Member 56 28/04/2020
Director/Board Member 65 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
10/14/26 A Sell

Executive/Senior Manager

-647 0.0001%
8/20/26 A Buy

Chief Executive Officer

1,506 0.0001%
8/20/26 A Buy

Head of Human Resources

54 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.85%-4.76%-2.50%-1.91% 113B
-1.88%-4.98%+29.21%+126.94% 1,232B
-2.10%-5.66%+32.08%+78.43% 656B
-0.97%-3.83%+21.58%+104.74% 506B
-1.04%-1.80%+28.69%+68.33% 382B
-3.17%-9.11%+40.52%+30.07% 340B
-3.22%-5.20%+24.48%+50.97% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-0.67%-5.81%+28.48%+65.78% 240B
-0.86%-0.45%+30.55%+120.00% 210B
Average -1.90%-2.12%+23.09%+67.50% 425B
Weighted average by Cap. -1.85%-2.61%+26.40%+85.08%

Financials

2026 *2027 *
Net sales 48.57B 53.31B 44.96B 40.67B 76.3B 4,979B 79.86B 544B 216B 2,691B 200B 196B 8,523B 51.86B 56.92B 48.01B 43.43B 81.46B 5,316B 85.26B 580B 230B 2,873B 214B 209B 9,100B
Net income 7.64B 8.39B 7.08B 6.4B 12.01B 783B 12.57B 85.53B 33.93B 423B 31.47B 30.81B 1,341B 9.21B 10.11B 8.52B 7.71B 14.46B 944B 15.14B 103B 40.87B 510B 37.92B 37.12B 1,616B
Net Debt 10.86B 11.91B 10.05B 9.09B 17.05B 1,113B 17.85B 121B 48.18B 601B 44.7B 43.76B 1,905B 6.36B 6.98B 5.89B 5.33B 9.99B 652B 10.46B 71.19B 28.24B 352B 26.2B 25.65B 1,116B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
19/11/26 €83.79 -2.85% 3,205,593
18/11/26 €86.25 -0.36% 1,635,950
17/11/26 €86.56 -1.99% 2,000,047
16/11/26 €88.32 +0.82% 1,519,229
13/11/26 €87.60 -0.43% 2,062,718
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
86.25EUR
Average target price
96.36EUR
Spread / Average Target
+11.72%